Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1980-09-22
1982-09-07
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
4242485, 424250, 424261, 544 60, 544125, 544361, 546 67, 546 68, C07D45712, A61K 3148
Patent
active
043483917
ABSTRACT:
The present invention provides compounds of formula I, ##STR1## wherein X is hydrogen, chlorine or bromine,
REFERENCES:
patent: 2533698 (1950-12-01), Stoll et al.
patent: 3185695 (1965-05-01), Bernardi et al.
patent: 3218323 (1965-11-01), Hofmann et al.
patent: 3232943 (1966-02-01), Hofmann et al.
patent: 3245996 (1966-04-01), Hofmann et al.
patent: 3270020 (1966-08-01), Hofmann et al.
patent: 3732231 (1973-05-01), Semonsky et al.
patent: 3880856 (1975-04-01), Bach et al.
patent: 3904757 (1975-09-01), Slater
patent: 3920664 (1975-11-01), Clemens et al.
patent: 3922347 (1975-11-01), Bach et al.
patent: 4005090 (1977-01-01), Semonsky et al.
Clemens et al.; Endocrinology, vol. 94, p. 1171 (1974).
Fehr Theodor
Stadler Paul
Stutz Peter
Honor Robert S.
Lee Mary C.
McGovern Thomas O.
Sandoz Ltd.
Sharkin Gerald D.
LandOfFree
Sulfonamido and sulfamoylamino-ergoline-I derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sulfonamido and sulfamoylamino-ergoline-I derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfonamido and sulfamoylamino-ergoline-I derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1342116